NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.22M | -8.09M | -8.32M | -8.13M | -9.47M |
| Total Depreciation and Amortization | 525.20K | 556.60K | 618.20K | 681.00K | 743.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 367.90K | 370.30K | 358.00K | 213.60K | 224.00K |
| Change in Net Operating Assets | -370.70K | -112.00K | 5.80K | -247.10K | 20.40K |
| Cash from Operations | -7.70M | -7.28M | -7.34M | -7.48M | -8.48M |
| Capital Expenditure | -84.30K | -94.50K | -94.50K | -94.50K | -57.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84.30K | -94.50K | -94.50K | -94.50K | -57.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.02M | 8.05M | 8.62M | 4.83M | 5.30M |
| Repurchase of Common Stock | -6.70K | -6.70K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.02M | 8.04M | 8.62M | 4.83M | 5.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.24M | 670.70K | 1.19M | -2.74M | -3.24M |